Nanobiotechnology Market By Technology (Bio-nanomaterials, Nanoparticles, Nanocrystals, Quantum dots, Liposomes, Polymer Structures Dendrimers, Nanopores, and Integrated Nanostructures), By Service Provider (Drug Delivery, Sequencing, Biologic Imaging, Research Tools, and Microbicide) - Growth, Share, Opportunities & Competitive Analysis, 2016 - 2023

This report on nanobiotechnology market studies various technologies and application. Nanobiotechnology deals with biological and biochemical applications or applications. Nanobiotechnology mostly studies existing elements of living organisms and nature to fabricate new nano-devices. The potential uses and benefits of nanotechnology are vast. The major applications of nanobiotechnology exist in biomedical field and are primarily targeted towards development of novel drug delivery systems, and it is expected to remain the major application of nanobiotechnology throughout the forecast period.

For the purpose of this study, the global nanobiotechnology market on the basis of technology type is segmented into nanoparticles, nanocrystals, quantum dots, liposomes, polymer structures dendrimers, nanopores, and intergrated nanostructures. Market size estimates and forecast for these segments for the period 2013 to 2023 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2023, considering 2015 as the base year.

On the basis of application type nanobiotechnology market is segmented as drug delivery, sequencing, biologic imaging, research tools and microbicide. Market size estimates and forecast for these segments for the period 2013 to 2023 are provided in terms of USD Mn along with the respective compounded annual growth rates (CAGRs) for the period 2016 to 2023, considering 2015 as the base year.

The nanobiotechnology market has been geographically categorized into major regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geography market is further split to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, Brazil, and GCC countries. Market size and forecast for these segments during 2013 to 2023 and their CAGRs for the period 2016 to 2023 are provided in this report.

The major key players profiled in the nanobiotechnology market are on the basis of various characteristics such as business description, financial health and budget allocation, product portfolio, and news coverage. The key players profiled in this report are Aduro BioTech, Calando Pharmaceuticals Inc., Baxter International, Inc., Fresinuns Kabi AG, Smith & Nephew plc, Biosante Phosphate Pharmaceuticals Inc., Celgene Corporation, Elan Pharmaceuticals Inc., Flamel Technologies Inc., Nanophase Technologies Corporation, Sigma Aldrich Company, Dendritic Nanotechnologies Inc. and SkyePharma Pharmaceuticals.

Based on the type of application, the global nanobiotechnology market is segmented as follows:

  • Drug Delivery
  • Sequencing
  • Biologic Imaging
  • Research Tools
  • Microbicide

On the basis of application nanobiotechnology market is segmented into drug delivery, sequencing, biologic imaging, research tools and microbicide.  In base year 2015, drug delivery and sequencing segments were observed as the largest segments of nanobiotechnology accounted for the market share of around 55%. Biotechnology and pharmaceutical industries are expected to remain the largest end-users of nanobiotechnology. Market experts suggested that drug delivery is the most crucial pharmaceutical application and now is the most focused area in nanobiotechnology. In drug delivery application apart from solving solubility issues of drug it also assists to enhance intracellular delivery possibilities and the level of skin permeability in transdermal drug delivery. Thus, nanobiotechnology possesses the potential to develop breakthrough interface systems that allows interaction between novel electronic devices and biological systems.

Nanobiotechnology Market

Based on the type of technology, the nanobiotechnology market is segmented into:

  • Bio-nanomaterials
  • Nanoparticles
  • Nanocrystals
  • Quantum dots
  • Liposomes
  • Polymer Structures Dendrimers
  • Nanopores
  • Integrated Nanostructures

In base year 2015, the segments liposomes and polymer structure dendrimers collectively account for the major market share of around 50% and are expected to maintain market dominance throughout the forecast period. The rising prevalence of cancer, increasing public awareness related to novel treatments for cancer, and constant technological upgradation in the field of nanotechnology research and development. The major restrains of this market especially in emerging and underdeveloped economies are scarcity of resources and mounting technological cost. However, rising demand from pharmaceutical domain is expected to open up novel growth opportunities within the forecast period. Market experts suggest that nanobiotechnology also possess the capability to develop breakthrough interface systems between physical objects and living cells to allow interaction of modern electronic devices with biological systems. The decades of in-depth research and development in nanobiotechnology is now assisting access to novel avenues of healthcare such as synthesis of advanced nanofabricated systems and devices for treating several untreatable diseases.

Nanobiotechnology Market

For the purpose of this study, the global nanobiotechnology market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Nanobiotechnology Market 

In base year 2015, North America accounted for the largest share in the global nanobiotechnology market, followed by Europe, Asia-Pacific, LATAM and MEA. The Asia-Pacific region (comprising Japan, China and India as major countries) is anticipated to grow at the fastest CAGR during the forecast period 2016 - 202. The key factors assisting the growth of nanobiotechnology market in North America and Europe are such as rising prevalence of cancer, high acceptance rate in case of novel mode of treatments, high accessibility to advanced healthcare infrastructure and favorable environment for nanobiotechnology–based research and development. Asia-Pacific was observed as the fastest growing region throughout the forecast period 2016 – 2023 due to rising public awareness related to cancer diagnosis and treatment, developing healthcare services and research and development infrastructure, and high market penetration and acceptance of novel treatment technologies. The major restrains of this market especially in emerging and underdeveloped economies are scarcity of resources and mounting technological cost. However, rising demand from pharmaceutical domain is expected to open up novel growth opportunities within the forecast period.

Choose License Type
Published Date:  Aug 2016
Category:  Technology & Media
Report ID:   58032
Report Format:   PDF
Pages:   120
Rating:    4.3 (55)
Connect With Us
+1-408-641-3282
24/7 Research Support